These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3373950)

  • 1. [Clinical significance of genetically determined polymodality of the distribution of quinidine elimination rates].
    Kholodov LE; Glezer MG; Makharadze RV; Kunchuliia LSh; Sokolov AV
    Kardiologiia; 1988 Feb; 28(2):56-9. PubMed ID: 3373950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The polymorphism of pachycarpine oxidation].
    Piotrovskiĭ VK; Belolipetskaia VG; Rumiantsev DO; Metelitsa VI
    Eksp Klin Farmakol; 1992; 55(4):56-8. PubMed ID: 1458193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-arrhythmic effect of pharmacokinetics of quinidine in middle-aged and elderly patients with a stable form of atrial fibrillation].
    Korkushko OV; Shatilo VB; Butenko AG; Pisaruk AV
    Klin Med (Mosk); 1987 Aug; 65(8):33-8. PubMed ID: 3682730
    [No Abstract]   [Full Text] [Related]  

  • 4. Quinidine disposition in relation to antipyrine elimination and debrisoquine phenotype in alcoholic patients with and without cirrhosis.
    Debruyne D; Gram LF; Grollier G; Camsonne R; Agron L; Dao MT; Lacotte J; Bigot MC; Moulin M
    Int J Clin Pharmacol Res; 1989; 9(5):319-25. PubMed ID: 2625371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimal treatment with quinidine based on a study of its pharmacokinetics].
    Kholodov LE; Glezer MG; Dragunov AA; Sokolov AV; Kunchuliia LSh
    Kardiologiia; 1988 Oct; 28(10):14-8. PubMed ID: 3226043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioversion of atrial fibrillation to sinus rhythm using quinidine given in rapid administration.
    Cotoi S
    Physiologie; 1983; 20(4):251-4. PubMed ID: 6419244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged quinidine half-life with associated toxicity in a patient with hepatic failure.
    Stanek EJ; Simko RJ; DeNofrio D; Pavri BB
    Pharmacotherapy; 1997; 17(3):622-5. PubMed ID: 9165569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined administration of quinidine and propafenone for atrial fibrillation: the CAQ-PAF study.
    O'Hara GE; Philippon F; Gilbert M; Champagne J; Michaud V; Charbonneau L; Pruneau G; Hamelin BA; Geelen P; Turgeon J
    J Clin Pharmacol; 2012 Feb; 52(2):171-9. PubMed ID: 21508180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent quinidine-induced digoxin toxicity after withdrawal of pentobarbital: a case of sequential drug interactions.
    Chapron DJ; Mumford D; Pitegoff GI
    Arch Intern Med; 1979 Mar; 139(3):363-5. PubMed ID: 426582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination treatment of atrial arrhythmias with quinidine-verapamil].
    Gülker H; Bramann HU; Brisse B; Kuhs H
    Med Klin; 1980 Feb; 75(5):196-8. PubMed ID: 6156393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
    Trappe HJ; Pfitzner P
    Med Klin (Munich); 1996 Oct; 91(10):617-25. PubMed ID: 9019638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of debrisoquine phenotype and of quinidine on mexiletine disposition in man.
    Turgeon J; Fiset C; Giguère R; Gilbert M; Moerike K; Rouleau JR; Kroemer HK; Eichelbaum M; Grech-Bélanger O; Bélanger PM
    J Pharmacol Exp Ther; 1991 Nov; 259(2):789-98. PubMed ID: 1941626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and effectiveness of oral quinidine in cardioversion of persistent atrial fibrillation.
    Kirpizidis C; Stavrati A; Geleris P; Boudoulas H
    J Cardiol; 2001 Dec; 38(6):351-4. PubMed ID: 11806093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of paroxysmal atrial fibrillation. Cardiac glycosides alone or combined with anti-arrhythmia agents?].
    Steinbeck G; Doliwa R; Bach P
    Dtsch Med Wochenschr; 1988 Dec; 113(48):1867-71. PubMed ID: 3143539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of effect of dietary salt on prehepatic first-pass metabolism: effects of beta-blockade and intravenous salt loading.
    Fromm MF; Darbar D; Dell'Orto S; Roden DM
    J Pharmacol Exp Ther; 1999 Jul; 290(1):253-8. PubMed ID: 10381784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered protein binding of quinidine in patients with atrial fibrillation and flutter.
    McCollam PL; Crouch MA; Watson JE
    Pharmacotherapy; 1997; 17(4):753-9. PubMed ID: 9250553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quinidine treatment of paroxysms of atrial fibrillation and flutter].
    Kalvelis AD; Braun VB; Dumesh SZ; Orlova VP; Gurvich TR
    Klin Med (Mosk); 1984 Mar; 62(3):103-7. PubMed ID: 6716916
    [No Abstract]   [Full Text] [Related]  

  • 18. Elimination kinetic of high polar metabolites pool of quinidine from human serum.
    Camsonne R; Moulin MA; Charbonneau P; Bazin C
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):74-5. PubMed ID: 3988396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination of quinidine and verapamil in auricular fibrillation].
    Sobrino JA; Maté I; Calvo L; Plaza I; Rico J; Moreno I; Mesa JM
    Rev Esp Cardiol; 1989 Apr; 42(4):262-6. PubMed ID: 2781120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of digitalis glycosides in atrial fibrillation].
    Knez A; Haberl R; Steinbeck G
    Z Kardiol; 1994; 83 Suppl 5():71-3. PubMed ID: 7846948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.